Buradasınız

Anasayfa » Content

HEMOROİDLERİN MEDİKAL TEDAVİSİ

Journal Name:

  • Cerrahpaşa Tıp Dergisi

Publication Year:

  • 2004

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Better understanding of the pathophysiology and anatomy of the anal canal has added to increased success in the treatment of hemorrhoids. Current therapies of hemorrhoids are: 1. Conservative/medical management, 2. Non excisional invasive therapy, 3. Surgical treatment. The choice of treatment methods depends on the severity and type of symptoms, the degree of prolapse, the expertise of the surgeon and equipment available.
Bookmark/Search this post with
Abstract (Original Language): 
Anal kanalın patofizyolojisi ve anatomisi-nin daha iyi anlaşılması hemoroid tedavisinde başarının artmasında katkıda bulunmuştur. Hemoroidlerin Güncel Tedavileri: 1. Konservatif/Medikal tedavi 2. Non-eksizyonel invazif tedavi 3. Cerrahi Tedavi Tedavi Metodlarının Seçimi: Semptomla-rın ciddiyeti ve tipine, prolapsin derecesine, cerrahın becerisine ve teknik donanıma bağlı-dır. Hastaların çoğunda hemoroidlerin onserva-tif-medikal tedavisi başarı ile uygulanabilir. Tedavi seçenekleri defekasyon alışkanlıkları hakkında önerilerden diyetsel değişiklikler, lo-kal hijyen, oral vazotopik ilaçlar ve topikal ajanlara kadar değişir. Bununla birlikte, hemoroidlerin ve kompli-kasyonlarının neden olduğu belli semptomların farmakolojik tedavileri konusunda halen tartış-ma mevcuttur. Bu çalışmanın amacı hemoroid-lerde medikal tedavinin rolünün değerlendiril-mesidir.
FULL TEXT (PDF): 
PDF icon arastirmax-hemoroidlerin-medikal-tedavisi.pdf
  • 4
188-193
  • Turkish

REFERENCES

References: 

1. Keighley M.R.B., Williams N.S. Hemorrhoidal Disease “Surgery of the Anus, Rectum &Colon Vol-J 3rd edition W.B.Saunders, London, 1993; 351-427.
2. Johanson J.F, Sonnenberg A. The prevalence of hemorrhoids and chronic constipation. An epidemiologic study. Gastroenterology, 1990; 93: 380.
3. Prasad GC, Prakash V., Tendon A.K. Deshphande P.J. Studies on etiopathogenesis of hemorrhoids. Am J Proctol. 1976; 27: 33-41.
4. Johanson J.F., Sonnenberg A. Temporal changes in the occurrence of hemorrhoides in the United States and England Dis Colon Rectum, 1991; 34: 585-91.
5. Sun WM Read NW, Shorthouse A.J. Hemorrhoids are associated with hypertrophy of internal anal sphincter but with hypertension of the anal cushions Br. J. Surg, 1992: 592-594.
6. Metcalfe C., Davey Smith G., Macleod J., Heslop P., Hart C. Self-reported stress and subsequent hospital admissions as a result of hypertension, varicose veins and hemorrhoids J Public Health Med, 2003; 25: 62-68.
7. Garry J.E. Hemorrhoids Current Surgical Teraphy Ed. Cameron J. L. 6th edition, Mosby Inc. Philadelphia, 1998; 265-281.
8. Mazier W.P. Hemorrhoids, Fissures and Pruritis Ani Surg.Clin N Am., 1994; 74: 1277-1292.
9. Sardinha T.C., Corman M.L. Hemorrhoids Surg. Clin N. Am., 2002; 82: 1153-1167.
10. Brief J.W., Zimmerman DD., Schouten W.R. Treatment of acute strangulated hemorrhoid by topical application of isosorbide dinitrate oinment Int J Colorectal Dis, 2000; 15: 253-254.
11. Perroti P., Antropoli C., Molina D. Conservative treatment of acute thrombosed external hemorrhoids with topikal nifedipine Dis Colon Rectum, 2001; 44: 401-404.
12. Aran J. Calcium dobesilate in the treatment of acute and chronic hemorrhoids: Report of a clinical trial Rivista Medica Della Svizzera, 1980; 45: 17-20.
13. Wissmer B. Doxium in the treatment of internal hemorrhoids O Medica, 1971; 1487: 1-5.
14. Berson I. A new synthetic veinotropic agent in proctology Schweiz, Rundschau Med (PRAXİS), 1972; 61: 52-54.
15. Mentes BB, Görgülü A., Tatlıcıoğlu E., Ayoğlu F., Ünal S. Efficiacy of calcium dobesilate in treating acute attacks of hemorrhoidal disease Dis Colon Rectum, 2001; 44: 1489-1495.
16. Cladera S.A., Blasco M.İ., Oliva B.E., Ramos D.F. Agranolocytosis induced by calcium dobesilate Med Clin, 1995; 105: 558-559.
17. Godeberg P. Daflon 500 mg in the treatment of hemorrhoidal disease: A demonstrated efficacy in comparison with placebo Angiology, 1994; 45: 574-578.
18. Cospite M. Double-blind, placebo controlled evaluvation of clinical activity and safety of Daflon 500 mg in the treatment of acute hemorrhoids Angiology, 1994; 45: 566-573.
Ekim-Aralık 2004 HEMOROİDLERİN MEDİKAL TEDAVİSİ; ERSAN VE ARK.
193
19. Diana G., Catanzaro M., Ferrara A., Ferrari P. Activity of purified diosmin in the treatment of hemorrhoids Clin Ter., 2000; 151: 341-344.
20. Tajana A., Boccasanta P., Micheletto G., Orio A. Results of the use of topical Diosmin in the treatment of acute hemorrhoid pathology. inerra Med., 1988; 79: 387-390
21. Thanapongsathorn W., Vajrabukka T. Clinical trial of oral Daflon in the treatment of hemorrhoids. Dis Colon Rectum, 1992; 35: 1085-1088.
22. Deen Kİ. Outpatient treatment of isolated strangulated hemorrhoids with single dose injection sclerotherapy and oral Daflon. Eur J. Surg., 1996; 162: 403-405.
23. Hoo YH., Foo CL., Seow-Choen F, Goh HS. Prospective Randomized controlled trial of a micronized flavonidic fraction to reduce bleeding after hemorrhoidectomy. Br. J. Surg., 1995; 82: 1034-1035.
24. Lyseng-Williamson KA, Perry CM. Micronised purified flavonoid fraction a review of its use in chronic veneous insufficiency, venous ulcers and hemorrhoids. Drugs, 2003; 63: 71-100.
25. Saleeby RG, Rosen L. Stasik J.J. Riether RD. Sheets J., Khubchamdani IT. Hemorrhoidectomy during preqnancy: Risk or relief? Dis Colon Rectum, 1991; 34: 260-261.
26. Buckshee K., Takkar D., Aggarwal N. Micronized flavonoid therapy in internal hemorrhoids of preqnancy. Int. Jour. Ganecol&Obstetr., 1997; 57: 145-151.
27. Beck D.E. Hemorrhoidal ldisease. In: Beck D.E.Wexner S.D. editors. Fundamentals of anorectal surgery. 2nd edition. London. W.B. Saunders Co p, 1998; 237-253.
28. Mazier W.B. Hemorrhoids In: Mazier WB. Levin DH.Luchtefeld M.A. editors. Surgery of the colon, rectum and anus. Philadelphia: W.B.Saunders 1995; 229-254.
29. Jeffery PJ, Ritchie JL., Parks AG. Treatment of hemorrhoids in patients with inflamatory bowel disease. Lancet, 1977; 1: 1084-85.
30. Wexner SD. AIDS: What the colorectal surgeon needs to know Prespect Colorect Surg., 1990; 2: 19-54.

Thank you for copying data from http://www.arastirmax.com